Previous studies have indicated that KAT2A is an essential candidate, and targeting KAT2A could significantly induce myeloid differentiation and apoptosis to suppress the tumor growth of acute myeloid leukemia (AML) (Tzelepis et al., 2016). This evidence concerns the gene KAT2A and acute myeloid leukemia.